Charles Schwab Investment Management Inc Harmony Biosciences Holdings, Inc. Transaction History

Charles Schwab Investment Management Inc

$601 Billion
Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 456,401 shares of HRMY stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

456,401

Previous 437,841 4.24%

Holding current value

$15.5 Million

Previous $13.8 Million 9.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$26.76 - $38.05 $496,665 - $706,208	18,560 Added 4.24%	456,401 $12.6 Million
Q2 2025 Aug 12, 2025	SELL	$27.94 - $35.91 $788,774 - $1.01 Million	-28,231 Reduced 6.06%	437,841 $13.8 Million
Q1 2025 Sep 15, 2025	BUY	$32.18 - $40.46 $908,473 - $1.14 Million	28,231 Added 6.45%	466,072 $15.5 Million
Q1 2025 May 09, 2025	SELL	$32.18 - $40.46 $191,664 - $240,979	-5,956 Reduced 1.26%	466,072 $15.5 Million
Q4 2024 Feb 06, 2025	BUY	$31.86 - $41.49 $3.2 Million - $4.17 Million	100,586 Added 27.08%	472,028 $16.2 Million

Q3 2024 Nov 12, 2024	SELL	$30.0 - $39.95 $97,980 - $130,476	-3,266 Reduced 0.87%	371,442 $14.8 Million
Q2 2024 Aug 12, 2024	BUY	$28.81 - $33.01 $34,341 - $39,347	1,192 Added 0.32%	374,708 $11.3 Million
Q1 2024 May 08, 2024	BUY	$29.93 - $35.06 $1.63 Million - $1.91 Million	54,349 Added 17.03%	373,516 $12.5 Million
Q4 2023 Feb 06, 2024	BUY	$19.2 - $33.78 $542,515 - $954,487	28,256 Added 9.71%	319,167 $10.3 Million
Q3 2023 Nov 08, 2023	BUY	$31.89 - $39.03 $1.36 Million - $1.67 Million	42,736 Added 17.22%	290,911 $9.53 Million
Q2 2023 Aug 09, 2023	BUY	$30.5 - $37.4 $740,113 - $907,548	24,266 Added 10.84%	248,175 $8.73 Million
Q1 2023 May 11, 2023	SELL	$30.8 - $53.92 $54,916 - $96,139	-1,783 Reduced 0.79%	223,909 $7.31 Million
Q4 2022 Feb 13, 2023	SELL	$45.4 - $60.91 $1.36 Million - $1.83 Million	-30,014 Reduced 11.74%	225,692 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $857,266 - $1.13 Million	20,382 Added 8.66%	255,706 $11.3 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $840,747 - $1.31 Million	-25,067 Reduced 9.63%	235,324 $11.5 Million
Q1 2022 May 13, 2022	SELL	$33.14 - $51.13 $220,646 - $340,423	-6,658 Reduced 2.49%	260,391 $12.7 Million
Q4 2021 Feb 11, 2022	BUY	$34.09 - $43.91 $1.19 Million - $1.54 Million	35,020 Added 15.09%	267,049 $11.4 Million
Q3 2021 Nov 16, 2021	BUY	$25.68 - $38.61 $4.74 Million - $7.13 Million	184,652 Added 389.75%	232,029 $8.89 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $872,515 - $1.12 Million	33,610 Added 244.13%	47,377 $1.34 Million
Q1 2021 May 17, 2021	BUY	$27.56 - $40.37 $22,626 - $33,143	821 Added 6.34%	13,767 $455,000
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $410,906 - $664,647	12,946 New	12,946 $468,000

Others Institutions Holding HRMY

# of Institutions

317

Shares Held

42.8M

Call Options Held

1.05M

Put Options Held

310K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.01B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Harmony Biosciences Holdings, Inc. Transaction History